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Differences that Matter: Major Cytotoxic T Cell–
Stimulating Minor Histocompatibility Antigens
and to elucidating the mechanisms underlying their im-
munogenicity.
Non-MHC polymorphisms that cause histoincompati-
Subramaniam Malarkannan,* Tiffany Horng,*
Peter Eden,† Federico Gonzalez,* Patty Shih,*
Nathalie Brouwenstijn,* Heiko Klinge,†
bility have been most extensively studied in the C57BL/6Greg Christianson,† Derry Roopenian,†
and BALB.B strains. These strains are identical in theirand Nilabh Shastri*‡
MHC but differ extensively in other background genes.*The Division of Immunology
Estimates of the number of H antigen polymorphismsDepartment of Molecular and Cell Biology
that distinguish these two strains have extended into theUniversity of California, Berkeley
hundreds (Bailey and Mobraaten, 1969; Bailey, 1999).Berkeley, California 94720
However; the B6 anti-BALB.B CD81 cytotoxic T cell†The Jackson Laboratory
(CTL) responses appear to be directed against a small
600 Main Street subset of the total potential H antigens (Wolpert et al.,
Bar Harbor, Maine 04609 1995; Nevala and Wettstein, 1996). Until recently, none
of these antigens were known at the molecular level,
thereby making it impossible to understand their unique
Summary characteristics that confer immunogenicity and immu-
nodominance. Using an expression cloning strategy, we
Despite thousands of genetic polymorphisms among recently isolated a cDNA clone that defined the H60
MHC matched mouse strains, a few unknown histo- locus and identified its naturally processed peptide
LYL8/Kb MHC complex as the ligand for B6 anti-BALB.Bcompatibility antigens are targeted by the cytotoxic T
CTL (Malarkannan et al., 1998). Here, we used this ex-cells specific for tissue grafts. We isolated the cDNA
pression cloning approach to isolate a cDNA that definesof a novel BALB.B antigen gene that defines the poly-
a distinct H locus, H28, and encodes a previously un-morphic H28 locus on chromosome 3 and yields the
known protein that yields the naturally processednaturally processed ILENFPRL (IFL8) peptide for pre-
ILENFPRL (IFL8) octapeptide presented by the Kb MHCsentation by Kb MHC to C57Bl/6 CTL. The CTL specific
molecule. We provide direct evidence that the H60 andfor the IFL8/Kb and our previously identified H60/Kb
H28 antigens dominate the CD8 T response in B6 micecomplexes represent a major fraction of the B6 anti-
immunized with BALB.B spleen cells. Unlike all the otherBALB.B immune response. The immunodominance of
known H loci, the H28 and H60 genes are transcribedthese antigens can be explained by their differential
in the BALB.B donor but not in host B6 cells. Both anti-
transcription in the donor versus the host strains and gens are expressed in professional APCs in the donor
their expression in professional donor antigen-pre- strain; H60 constitutively and H28 after induction with
senting cells. inflammatory cytokines. The findings provide the basis
for the emerging paradigms for immunity to histocom-
Introduction patibility antigens.
Even a few polymorphic amino acid substitutions in the Results
MHC molecules impose an insurmountable barrier to
the acceptance of tissue grafts by normal individuals Isolation of B6 Anti-BALB.B CD81 T Cell Clone
(Snell, 1948). However, when the MHC loci are identical and Its Target Antigen Gene
between the donor and the host, tissue grafts can still To probe the polymorphic antigenic differences be-
be rejected due to equally imposing barriers posed by tween the C57Bl/6 (B6) and its MHC matched BALB.B
other polymorphic differences–the minor histocompati- strains, we first established a polyclonal cytotoxic T cell
bility loci (H). Due to their central importance in determin- line from the spleens of B6 mice immunized with BALB.B
ing the final outcome of clinical transplants, the H loci spleen cells. The CTL line was fused to BWZ.36/CD8a
have been intensively studied for decades (Little, 1914). to generate lacZ inducible T cell hybrids (Sanderson and
At least 60 H loci have been genetically identified in Shastri, 1994). One of these hybridomas, BCZ104.2, was
mice and have been mapped to the mitochondrial as selected because it specifically responded to the donor
well as the sex and autosomal chromosomes (Loveland BALB.B spleen cells (Figure 1A) but failed to recognize
et al., 1990; Simpson et al., 1997). The H loci are the our previously identified H60 locus derived peptide (Ma-
source of antigenic peptides presented by the classical larkannan et al., 1998). The response of the BCZ104.2
as well as the nonclassical MHC molecules in cells of T cells required the Kb MHC molecule, because it was
the tissue donor or the recipient of a bone marrow graft inhibited by an anti-Kb monoclonal antibody but not with
(Loveland et al., 1990; Wallny and Rammensee, 1990). anti-Db or with anti-Ab antibodies (Figure 1B). The
The resulting T cell responses to these key H peptide/ BCZ104.2 T cell was therefore specific for a polymorphic
MHC complexes subsequently cause chronic graft re- antigen presented by the Kb MHC I molecule in the donor
jection or graft versus host disease. Identifying the anti- BALB.B spleen cells.
gen peptides and their genetic sources is therefore cen- To identify its cognate antigen, the BCZ104.2 T cell
tral to understanding H antigens at a molecular level hybrid was used to probe a cDNA expression library
prepared from cells derived from (BALB/c 3 BALB.B)F1
mice. The library was screened in pools of z50 cDNAs/‡ To whom correspondence should be addressed (e-mail: nshastri@
socrates.berkeley.edu). well together with the Kb gene in recipient COS cells.
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Figure 1. Generation of B6 Anti-BALB.B T
Cell Hybrid and Isolation of Its Antigen Gene
The BCZ104.2 T cell hybrid recognizes a poly-
morphic H antigen expressed in BALB and
129/J backgrounds that is presented by the
Kb MHC molecule. (A) 1 3 105 BCZ104.2 T
cells were cocultured overnight with varying
numbers of spleen cells from the indicated
strains or (B) with 6 3 104 BALB.B cells and
dilutions of anti-Kb, Db, or Ab monoclonal anti-
bodies. The T cell response was measured
by the induction of lacZ activity by the con-
version of the substrate chlorophenolred-b-
D-galactopyranoside (CPRG) at 595 nm and
655 nm wavelength as reference. (C) Plas-
mids from a (BALB/cXBALB.B)F1 cDNA li-
brary were transiently transfected into 3 3
104 COS cells as pools or (D) from individual
colonies of the positive pool together with Kb
cDNA. Two days later, BCZ104.2 T cells were
added, and after overnight culture their lacZ
response was measured as above.
Two days later, the BCZ104.2 T cells were added and a band of z50 kDa showing that the first ATG codon
was predominantly used for translation initiation (Figuretheir response measured by the induced b-galactosi-
dase activity. Among a total of z105 cDNA pools tested, 2B). Likewise, the previously isolated H60 cDNA yielded
a band corresponding to z30 kDa, confirming that thisthe response of BCZ104.2 T cells to one of the pools
was clearly above background (Figure 1C). Individual cDNA also yields a protein with the expected molecular
weight (Malarkannan et al., 1998).bacterial colonies, obtained by retransforming the DNA
mixture from this pool were rescreened, and the plasmid Comparison of the NS1178 protein sequence with
NS1178 was identified as capable of stimulating the those in the sequence databases did not yield an exact
BCZ104.2 T cells (Figure 1D). The BCZ104.2 T cell re- match to any known gene (http://www.ncbi.nlm.nih.-
sponse to COS cells transfected with the NS1178 cDNA gov). The closest homology with 49% amino acid identi-
was specific and required coexpression of the Kb MHC ties was to a hypothetical protein (NP006811.1) ex-
I molecule (see below). We conclude that the NS1178 pressed in human osteoblasts and with 36% amino
cDNA was a likely candidate encoding the BALB anti- acid identities to four other proteins (P27473, A43676,
gen that was recognized by the Kb restricted BCZ104.2 NP006408.1, S48218). The latter proteins have been
T cell. characterized as microtubular aggregate proteins asso-
ciated with hepatitis antigens in humans and nonhuman
primates. These similarities and the absence of mem-NS1178 cDNA Encodes a Novel Gene Product and
brane translocation or nuclear localization signals sug-Maps the Antigen Gene to the Differentially
gest that NS1178 encodes a cytoplasmic protein in con-Transcribed Polymorphic H28 Locus
trast to H60, which, based upon its sequence, is a typeThe nucleotide sequence of the NS1178 cDNA clone
I transmembrane protein.was determined to characterize the donor gene and its
To define the molecular basis of the antigenic poly-putative protein product. The 2279 nucleotide sequence
morphism at the NS1178 locus, we examined restrictionof NS1178 revealed a 1320 nucleotide open reading
fragment length polymorphisms (RFLP). Southern blotsframe encoding 449 amino acids (Figure 2A). To charac-
of genomic DNA from the BALB.B and B6 strains probedterize the putative protein product the NS1178 cDNA
with the NS1178 cDNA revealed HindIII, BamHI, and XbaIwas used as a template in an in vitro transcription/trans-
lation assay. Analysis of the labeled products revealed RFLP (data not shown). The strain distribution pattern of
Major Minor Histocompatibility Antigens
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Figure 2. NS1178 cDNA Encodes a Novel Protein that Defines the Polymorphic, Differentially Transcribed H28 Locus
(A) Nucleotide sequence and predicted translation product of the NS1178 cDNA. The antigenic peptide is boxed.
(B) Products of in vitro protein translation reactions using the NS1178, H60, and control luciferase cDNAs.
(C) Southern blot analysis of genomic DNA from C57Bl/6, BALB.B, or the congenic B6.C-H28c digested with XbaI and probed with 32P-labeled
NS1178 probe. Molecular weight markers are indicated on the left.
(D) Northern blot analysis of total RNA from the BALB.B, BALB/c, C57Bl/6 spleen cells, or IFNg-induced RAW cells probed with 32P-labeled
NS1178 or H47 cDNA probes. Molecular weight markers are indicated on the right.
DNAs from a panel of BxC recombinant inbred lines from the B6, BALB.B, and the B6.C-H28c congenic strain
(Bailey, 1975). In contrast to the single z10 kb band inderived from the parental BALB/c and B6 strains sug-
gested a linkage concordant with an interval on chromo- the B6 strain, each of the four (8, 2, 1, and 0.8 kb) bands
detected in the BALB.B DNA were also found in thesome 3 containing the H28 locus. This linkage was con-
sistent with a pattern previously described for the CTT-3 B10.C-H28c strain (Figure 2C). We conclude that the
NS1178 cDNA detected a polymorphic locus that segre-and IDE-3 antigens by Karre and Wettstein laboratories
(Wolpert et al., 1995; Nevala and Wettstein, 1996). To gated with the H28 congenic interval.
Northern blot analysis with the NS1178 probe intest this hypothesis directly, we examined RFLP in DNA
Immunity
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Figure 3. The IFL8 Octapeptide Is the Minimal Antigenic Peptide within the NS1178 Gene Product
(A) Schematic representation of deletion constructs of the NS1178 cDNA.
(B) Sequences of candidate antigenic peptides as predicted by the Kb binding motif.
(C) Plasmid DNAs of the indicated deletion constructs or the minigenes encoding IFL8 antigenic peptide were transiently transfected into
COS cells together with either Kb MHC or Db MHC cDNA. The BCZ104.2 T cells were added after 48 hr and assayed for lacZ activity the next
day.
(D) The lacZ response of either BCZ104.2 or the H60-specific BCZ103.1 T cells after overnight culture with Kb-L cells and varying concentrations
of either synthetic IFL8 (ILENFPRL), FFL9 (F-IFL8) peptides, or the H60 derived peptide LYL8 (LTFNYRNL). The lacZ responses were measured
as in legend to Figure 1.
spleen cells showed that this gene was transcribed in and 3B). Three deletion constructs lacking sequences 39
to the internal HindIII (DHind), XbaI (DXba), and BamHIthe spleen cells and in interferon-g-induced RAW cells
derived from the BALB background. In contrast, tran- (DBam) were prepared and tested for their ability to
generate the BCZ104.2-stimulating ligand in recipientscripts for another H antigen gene, H47 (unpublished
data) were found in all the samples confirming the integ- cells in the presence of the cotransfected Kb cDNA (Fig-
rity of the RNA samples. Thus, despite the presence of ure 3C, left panel). The response of the BCZ104.2 T cells
complementary sequences in the B6 genome, expres- to the DHind and DXba but not to DBam constructs
sion of the NS1178 gene was not detectable in the spleen suggested that the antigenic peptide was encoded in
cells. the region flanked by the XbaI and BamHI sites that
Taken together, these observations demonstrate that contained the Kb2 candidate epitope. Indeed, a mini-
NS1178 cDNA defines the H28 locus, which is a polymor- gene construct (M-IFL8) encoding only the Kb2 se-
phic, differentially expressed locus in the BALB and B6 quence (Figure 3B) with an ATG codon for efficient trans-
strains. This locus encodes a novel 50 kDa protein with lation initiation strongly stimulated BCZ104.2 T cells.
no known function other than serving as a precursor for Most importantly, none of the recipient cells coexpress-
a naturally processed peptide presented by the Kb MHC ing the Db MHC with any of these DNA constructs gener-
molecule. ated the T cell–stimulating ligand (Figure 3C, right panel).
Thus, the Kb MHC as well as the antigen gene were
strictly required for BCZ104.2 T cell stimulation.ILENFPRL Is the Antigenic Octapeptide within NS1178
Presented by the Kb MHC Molecule Conclusive proof that the Kb2 octapeptide was the
antigenic peptide was obtained by testing the syntheticNext, we identified the antigenic peptide encoded within
the NS1178 cDNA that was presented by the Kb MHC ILENFPRL (IFL8) peptide in an exogenous assay (Figure
3D). The synthetic IFL8 peptide stimulated the BCZ104.2and recognized by the BCZ104.2 T cells. First, using the
xxxx(F,Y)xx(I,L,V,M) consensus sequence of Kb binding T cells at picomolar concentrations but failed to stimu-
late the H60-specific BCZ103.1 T cell even at a 100,000-peptides (Falk et al., 1991), we identified four peptides,
Kb1 through Kb4, that matched this sequence (Figures 3A fold higher concentration. As a reciprocal specificity
Major Minor Histocompatibility Antigens
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Figure 4. The H28 and H60 Specificities Dominate the B6 Anti-BALB.B CD8 T Cell Response
(A) Antigen-specific target cell lysis by three independently derived B6 anti-BALB.B CTL lines. RMA/S cells were used as targets in the
presence of 100 nM concentration of the indicated H antigen peptides. The Kb binding SFV8 peptide, derived from the MuLV gene, was used
as a negative control.
(B) Flow cytometric analysis of CD81 cells that secrete interferon-g during a 5 hr incubation with the indicated peptides. The results in the
top panels were obtained with a bulk B6 anti-BALB.B CTL line and those in the bottom panels with ex vivo spleen cells from B6 mice immunized
thrice with BALB.B spleen cells. The numbers indicate the percentage of cells in that quadrant.
control, the BCZ103.1 but not the BCZ104.2 T cells re- by the expression of the antigenic IFL8 peptide, we
immunized B6 mice with spleen cells from the congenicsponded to picomolar concentrations of the H60 en-
coded LYL8 peptide. Addition of a single phenylalanine B6.C2H28 strain. The CTLs lysed T2-Kb target cells incu-
bated with 10 nM IFL8 peptide (specific lysis 5 43.4 6at the N terminus of the IFL8 peptide (FIL9) caused a
greater than 10,000-fold loss of activity. We conclude 1.5%) compared to lysis of the same target cells incu-
bated with the irrelevant Kb binding VSV peptide (specificthat IFL8 was the optimal antigenic peptide within the
NS1178 cDNA that was presented by the Kb MHC to the lysis 5 0.6 6 0.1%). Thus, the NS1178 and the IFL8
peptide defined the molecular basis for the polymorphicBCZ104.2 T cells.
To further confirm that the H28 locus was defined H28 locus in the BALB background.
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The Anti-H28 and Anti-H60 Specificities Dominate but H-Y antigen expression was observed only in the
pre-B cell line and not in the RAW cells even in thethe B6 Anti-BALB.B CTL Response
The H28 and H60 antigens were identified using individ- presence of the cytokines. This result suggested that
the expression of H antigens was not ubiquitous andual CD81 T cell clones in the B6 anti-BALB.B CTL popu-
lation. To determine if these two specificities were fre- constitutive but was cell type specific and inducible.
We then examined the expression of these four Hquent, we analyzed polyclonal B6 anti-BALB.B CTL.
First, three independently derived bulk CTL lines from antigens in different tissues isolated from male BALB.B
donor cells. The H3a autosomal antigen is present infemale B6 mice immunized with male BALB.B spleen
cells were tested for their lytic activity against H-2b target both B6 and BALB.B strains (Zuberi et al., 1998), but the
H-Y antigen is expressed only in male cells (Greenfield etcells incubated with the IFL8 (H28), LYL8 (H60), or the
SIL9 (H13b) peptides in a JAM assay (Matzinger, 1991) al., 1996). The naturally processed peptides of H3a
(ACL9) and HY (WI9) are presented by the Db MHC I(Figure 4A). A high level of IFL8- and LYL8-specific lytic
activity was found in all three CTL lines that had been molecule present in both B6 and BALB.B strains. Ac-
cordingly, untreated or cytokine-treated female B6restimulated six to eight times in vitro. The cytolytic
activity was specific because it was not observed to- spleen cells stimulated only the H3a-specific, but not
the H28-, H60-, or the HY-specific T cell hybrids. In theward target cells in the presence of SFV8, an irrelevant
Kb binding peptide. Significantly, lytic activity was not presence of the appropriate peptide, all the T hybrids
responded strongly to the B6 spleen cells. In contrast,detected toward target cells incubated with the SIL9
peptide, which represents the H13 histocompatibility the BALB.B spleen cells failed to stimulate the H28-
specific T cells but stimulated the H60-, H3a-, and HY-polymorphism between the B6 and BALB.B strains nor
to the Uty derived WI9 peptide (data not shown) (Green- specific T cells without any cytokine treatment. Again,
when the spleen cells were pretreated with IFNa, b, orfield et al., 1996; Mendoza et al., 1997). Thus, anti-H28
and anti-H60 CTL were reproducibly elicited in the B6 g, but not TNFa, the H28-specific T cells responded
strongly. The bone marrow cells showed a similar reac-anti-BALB.B response and dominated the response to
other known H antigens. tivity pattern with some quantitative differences in the
basal and cytokine-induced responses. We concludeThe frequency of H28- and H60-specific clones among
the B6 anti-BALB.B CTLs was determined by analysis that unlike the other constitutively expressed H anti-
gens, expression of the H28 antigen was barely detect-of T cell hybridomas generated by fusing each of the
three CTL lines with the BWZ36/CD8a fusion partner. able in untreated cells but was strongly induced by cer-
tain inflammatory cytokines.Analysis of individual hybridomas showed 22% (24) and
37% (40) of 106 anti-BALB.B hybrids tested were spe-
cific for the H28 and H60 derived LYL8 and IFL8 pep- Transcriptional Regulation, Abundance, and MHC
tides, respectively (data not shown). To ensure that this Binding Affinity of Naturally Processed H60
estimate reflected the actual frequency of T cells spe- and H28 Antigenic Peptides
cific for these antigens, we also determined the fre- To assess if the cytokine-induced upregulation of H28-
quency of CD81 T cells that produced interferon-g after specific T cell activation by BALB.B-derived cells was
antigen stimulation of the bulk CTL line. Again, 16% and due to transcriptional activation of the H28 gene, we
39% of all CD81 T cells produced interferon-g when they analyzed the RNA from the RAW and bone marrow cells
were stimulated with the LYL8 and IFL8 peptides relative after treatment with different cytokines. Northern blot
to negligible responses to no peptide or to an irrelevant analysis with the NS1178 (H28) probe showed that in
Kb binding SFV8 peptide (Figure 4B). Further evidence both the RAW as well as in bone marrow cells, H28
that these T cells arose during the immune response in transcription was barely detectable in resting cells or
the animal rather than being enriched during in vitro those treated with TNFa (Figure 6A). In contrast, H28
culture was obtained by measuring the frequency of transcription was strongly induced by all interferons. To
IFNg1 CD81 T cells ex vivo. Remarkably, IFNg1 anti- determine whether the upregulation of H28 transcription
LYL8 and anti-IFL8 CD81 T cells were readily detected and of APC function led to an increase in the generation
in the immunized spleens at a frequency of 7%–10% of of naturally processed peptides, we examined the natu-
the total CD81 T cells. We conclude that the anti-H28 rally processed H28 and H60 peptides in HPLC fraction-
and anti-H60 T cell clones dominate the host B6 CTL ated cell extracts of IFNg-induced RAW macrophages.
response to the donor BALB.B cells. A single activity peak was found in the HPLC fractions
tested with the H60- and H28-specific BCZ103.1 and
BCZ104.2 T cells (Figure 6B). These activity peaks co-H Antigen Expression Can Be Constitutive or Induced
To assess the potential factors that could contribute to eluted with the synthetic H60 and H28 derived LYL8 and
IFL8 peptides, respectively, indicating that the naturallythe immunodominance of the H28 and H60 antigens,
we first analyzed their expression in different cell types. processed peptides were identical to their synthetic
counterparts and that no qualitative changes had oc-In initial experiments, we noticed that both a macro-
phage (RAW309Cr.1) and a pre-B (C3) cell line stimu- curred in antigen processing. Quantitative estimates of
the H60 and H28 peptides in the untreated and inter-lated the H60-specific T cell hybridoma clones but failed
to stimulate the H28-specific T cell hybrid. However, feron-g treated RAW cell extracts showed that the
amount of H60 peptide remained unchanged at z6–15antigen presentation activity was strongly induced in
the macrophage line, in contrast to the pre-B cell line, copies/cell, but the amount of H28 peptide increased
from undetectable to z200 copies/cell. We concludeupon incubation with a panel of inflammatory cytokines
(Figure 5). Expression of H28-specific antigen presenta- that cytokine treatment of macrophages specifically
upregulated H28 gene transcription and as a conse-tion was strongly induced with all the inteferons (a, b,
and g) tested, but not by TNFa. Furthermore, the H3a quence expression of the IFL8/Kb complex that directly
accounted for the augmentation in the T cell response.antigen was constitutively expressed in both cell lines,
Major Minor Histocompatibility Antigens
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Figure 5. Constitutive and Inducible Expression of H Antigens in Cell Lines and Lymphoid Cells
Expression of H antigens was measured by the ability of different cells to stimulate T cells specific for the H28, H60, H3a, and HY antigens.
RAW and C3 are transformed cell lines of the macrophage and B cell lineage. Spleen or bone marrow cells were from either B6 or BALB.B
mice. The cells were incubated overnight in either medium alone or with the indicated cytokines, washed, and cocultured with lacZ inducible
T cell hybrids specific for each H antigen. As positive controls, the specific H antigen peptide was added to the B6 cells. The lacZ responses
were measured as in legend to Figure 1.
In addition to the increase in the overall amount of affinity of H28 as well as H60 antigens was comparable
to that of other MHC binding peptides.the naturally processed H28 peptide, it was also possi-
ble that the H antigen peptides were bound to MHC
molecules with an unusually high affinity. A competitive
binding assay was used to compare the binding affinity H Antigens Are Differentially Expressed
in Professional APCof H28 and H60 peptides, with other known Kb binding
peptides. The specific binding of the mab 25D1.16 to To identify the cells that express H antigens, we fraction-
ated the T, B, macrophages, or dendritic cells by flowits ligand, the ovalbumin derived SL8 peptide/Kb com-
plex, can be detected by flow cytometry on the surface cytometry using cell type-specific surface markers. The
fractionated cells were then used as APCs for stimulat-of RMA/S cells (Figure 6C) (Porgador et al., 1997). The
dose-dependent decrease in the mean fluorescence in- ing H28-, H60-, H3a -, or HY-specific T cells as such
or after overnight incubation with interferons or TNFatensity caused by the other peptides is a relative mea-
sure of how well these peptides bind Kb MHC. The H28 (Figure 7). Fractionated B or T cells were generally poor
in their ability to stimulate any of the T cells even afterand H60 derived LYL8 and IFL8 peptides specifically
inhibited the binding of SL8 to Kb MHC. The inhibition treatment with the cytokines. In contrast, untreated
macrophages and dendritic cells were excellent stimula-curves were, however, not significantly different from
those obtained with two other peptides of self (SFL8) tors of H60- and H3a-specific T cells. Expression of the
HY/Db ligand was detected primarily in macrophagesor viral (SFV8) origin. We conclude that the MHC binding
Immunity
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Figure 6. Inflammatory Cytokines Regulate Transcription of the H28 Locus and Increase Expression of Its Naturally Processed IFL8 Peptide
(A) Northern blot analysis of RAW or BALB.B bone marrow cells with the H28 probe. Total RNA was extracted from cells that had been cultured
overnight with 100 U/ml of the indicated cytokines. The same blot was also analyzed with a probe for the housekeeping cytochrome c gene
as a loading control.
(B) Naturally processed peptide extracts from uninduced and interferon-g-induced RAW cell line were fractionated by reverse phase HPLC.
The fractions were tested for presence of antigenic activity using H60 (BCZ103.1)- or H28 (BCZ104.2)-specific T cells. The peak elution times
for the synthetic LYL8 (H60) and IFL8 (H28) run under identical conditions are shown by a vertical arrow.
(C) The relative Kb binding affinity of peptides was assessed using a flow cytometric assay based upon the ability of peptides to compete
with the ovalbumin derived SL8 peptide for binding to Kb. Cell surface expression of the SL8/Kb was specifically detected with the 25D1.16
mAb. The peptides were IFL8, ILENFPRL; SFV8, SSWDFITV; LYL8, LTFNYRNL; SFL8, SVVEFTSL. The Db binding NP peptide, ASNENMETM,
was used as a negative control. The lacZ responses were measured as in legend to Figure 1.
and was far lower in the dendritic cells. Most signifi- Molecular Definition of H Loci
With tens of thousands of proteins, mammalian cellscantly, expression of H28 dramatically and specifically
are the most complex entity in the antigenic universeincreased in dendritic cells and macrophages after treat-
faced by the immune system. The full brunt of this com-ment with the interferons but not with TNFa. We con-
plexity is realized when host T cells respond with a veryclude that only a subset of H antigens are efficiently
high frequency to a multitude of different peptide/donorexpressed in professional APCs.
MHC complexes on allogeneic cells (Lindahl and Wilson,
1977; Rotzschke et al., 1991). In contrast, when the MHC
Discussion molecules are matched the host T cells respond only to
non-MHC antigens–those defined by the H loci. There
The molecular identity of minor histocompatibility loci appears to be a large discrepancy between the number
and why they cause chronic graft rejection in MHC of potential H loci and those that have been experimen-
matched individuals has remained an enduring enigma. tally observed. Currently, more than 4000 polymorphic
We show here that the murine autosomal H28 locus differences are known to exist between the B6 and BALB
encodes a previously unknown protein that is the source genetic backgrounds as defined by PCR or RFLP analy-
of the naturally processed IFL8 octapeptide presented sis (http://www.informatics.jax.org/). Although many of
by the Kb MHC molecule. The nature of genetic polymor- these genetic polymorphisms may not be reflected in
phism at the H28 locus, and comparison with other H amino acid substitutions in protein sequences, this num-
loci, provide insights into the sources as well as the ber is expected to increase exponentially as genome
mechanisms of immunogenicity and immunodominance sequences become available. In contrast, experimental
estimates by Bailey and colleagues showed that a mini-of H antigens that are targeted by CTLs.
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Figure 7. Expression of H Antigens Is Cell Type Specific and Induced by Inflammatory Cytokines
BALB.B cells were sorted according to the expression of surface markers. The cells were incubated overnight in media containing 100 U/ml
of the indicated cytokines, washed, and then tested for their ability to stimulate T cell hybrids specific for H28, H60, H3a, or HY antigens. The
lacZ response was measured as in legend to Figure 1.
mum of 29 H loci can cause rejection of skin grafts the cell surface H60 protein itself. The normal cellular
functions and the consequences of the polymorphismsbetween the B6 and BALB.B strains (Bailey and Mo-
braaten, 1969). However, analysis using CTLs showed in H28 and most other H proteins still remain to be
discovered.that as few as five distinct specificities were dominant
in the CTL response to immunization with spleen cells All the H loci identified so far represent the structural
antigen genes that are the precursors for the naturally(Wolpert et al., 1995; Nevala and Wettstein, 1996). The
H loci that encode these dominant H epitopes are thus processed antigenic peptides presented by MHC mole-
cules. Nevertheless, the existence of transcriptionallythe key players that stand out among the large number
of potential H antigen disparities. regulated H loci raises the possibility that some H loci
may encode transcription factors that regulate the ex-The H loci represent natural polymorphisms that are
detected by CTL as novel peptide/MHC complexes, but pression of structural H antigens in trans. Note also
that the existence of transcriptionally regulated H locithey could have other functional consequences as well.
Indeed, it is remarkable that the H60 protein, described described here makes it impossible to match tissue do-
nors with the host by a simple test for DNA polymor-here as a source of the immunodominant LYL8/Kb com-
plex, was also recently identified as the ligand for the phisms alone.
NKG2D receptor expressed by a subset of murine NK
and CD81 T cells (Cerwenka et al., 2000; Diefenbach et
al., 2000). What role the interactions between the H60 Mechanisms of Immunogenicity and
Immunodominance of H Antigensligand and the NKG2D receptor play in the anti-H60 CTL
response is not known but could add another dimension The high fraction of B6 anti-BALB.B CTLs that were
specific for the H60 and H28 derived LYL8 and IFL8to potential mechanisms of immunodominance. For ex-
ample, the NKG2D1 CD8 T cells could engage not only peptides was striking. Not only did LYL8- and IFL8-
specific CTL account for .50% of all CD81 T cells inthe LYL8/Kb ligand via their TCR/CD8 receptors but also
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independently derived CTL lines, but they were also did not increase after interferon stimulation. Resting T
readily detected in ex vivo spleen cells. This analysis or B cells were uniformly low in their ability to present
of the frequency of antigen-specific CTL specific for either H28, H60, H3a, or HY peptides to appropriate T
transplantation antigens shows that as in responses to cells. These findings demonstrate that H antigens are
viruses or bacteria, certain specificities prevail (Busch selectively expressed in certain cell types and provide a
et al., 1998; Murali-Krishna et al., 1998). Thus, despite potentially powerful mechanism for immunodominance.
the existence of CTLs specific for the H13b and Uty Because dendritic cells are believed to be professional
derived SIL9 and WI9 peptides, these cells were not APC that initiate nai¨ve CD8 T cell responses in vivo, we
detected in the B6 anti-BALB.B response. Therefore, postulate that H antigens that are directly expressed in
CTL responses in the host do not include all possible donor dendritic cells have an advantage over those H
foreign epitopes in the donor but focus primarily on antigens that are not. An antigen such as H28 also be-
epitopes derived from H28 and H60 genes. longs to the former category because its expression can
Two different mechanisms have emerged to explain be induced by inflammatory cytokines that are inevitably
why donor H antigens are immunogenic in the host and produced during experimental procedures of surgery or
why the CTL responses are uni- or bidirectional. The injection. CTL responses to H antigens that are poorly
first mechanism was revealed by the identification of expressed by donor DC would lead to less efficient im-
the antigenic peptide derived from the mitochondrial munity and/or require that the host DCs acquire these
protein ND1 (Loveland et al., 1990). Polymorphisms antigens via the “cross-priming” mechanism. While thisamong the natural ND1 alleles results in presentation of
hypothesis provides a molecular explanation for the highpeptides with a single amino acid substitution by the
immunogenicity of “passenger leukocytes,” now knownnonclassical H2-M3 MHC molecule. Because both the
to be DCs, it also raises the key question of the relativedonor and host present self-ND1 peptides, reciprocal
efficiency of direct versus cross-priming mechanismsimmunizations elicit CTL responses specific for the do-
in generating CTL responses to H antigens (Bevan,nor ND1/H2-M3 complex–the CTL responses are bidi-
1976). The knowledge of dominant and subdominant Hrectional. A similar pattern of biallelic expression was
antigen genes, proteins, and their naturally processedalso observed for the autosomal H13 and H3a genes
peptides now makes it possible to address these hy-(Mendoza et al., 1997; Zuberi et al., 1998). In contrast,
potheses.the female anti-male CTL responses to the HY antigens
are unidirectional because only the Y chromosome en-
coded Uty and Smcy genes yield unique antigenic pep-
Experimental Procedurestide/MHC complexes (Scott et al., 1995; Greenfield et
al., 1996). However, these genes do have X chromosome Animals, Immunizations, and Cell Lines
homologs (Smcx and Utx) expressed in female cells, Inbred mouse strains C57BL/6, 129/J, BALB.B, and B6.C-H28c were
but they do not yield antigenic peptide/MHC complexes obtained from or bred at The Jackson Laboratory (Bar Harbor, ME)
because of substitutions that abrogate MHC binding. or at the animal care facility at the University of California, Berkeley,
The autosomal H28 and H60 genes are the most extreme CA. Immunizations, generation, and maintenance of cell lines and
as they are the first examples of donor H loci that are T cell hybrids has been described (Karttunen et al., 1992; Sander-
effectively null alleles in the host. The reasons for this son and Shastri, 1994; Malarkannan et al., 1998). The (BALB/
cxBALB.B)F1 derived RAW309Cr.1 cells were from ATCC.differential transcriptional regulation in the BALB and
B6 backgrounds remain to be determined but provide
the explanation for why unique H28 and H60 derived
T Cell Activation AssaysIFL8 and LYL8 peptides are displayed by the Kb MHC
T cell responses specific for peptide/MHC were measured by thein the donor BALB.B cells.
production of b-galactosidase (LacZ) activity in the T cell hybridsOne of the explanations proposed for immunodomi-
(Sanderson and Shastri, 1994). T cell hybrids (3–10 3 104) werenance is the binding characteristics of the antigenic
cocultured overnight with APC (2–5 3 104) either expressing thepeptide to MHC protein (Nevala and Wettstein, 1996;
antigen endogenously, transfected with antigen cDNA or with exog-
Sijts and Pamer, 1997; Chen et al., 2000). We failed enous peptides in 96-well plates. The peptide/MHC-induced T cell
to detect a significant difference between the binding response was assayed as lacZ activity using the substrate chloro-
affinity of the IFL8 and LYL8 peptides for the Kb MHC phenol red b-D-galactopyrannoside (CPRG). The conversion of
relative to other known peptides. Furthermore, neither CPRG to chlorophenol red was measured at 595 and 655 nm as
of these two naturally processed peptides was ex- a reference wavelength with a 96-well microplate reader (BioRad,
pressed at unusually high levels. In fact, the IFL8 peptide Richmond, CA). Cytolytic activity was detected by the JAM assay
was barely detected in functional or biochemical assays using 3H-thymidine labeled RMA/S cells in the presence of 100 nM
concentration of the indicated peptides (Matzinger, 1991).using resting APC. Expression of IFL8 was, however,
strongly induced after the cells were cultured with a, b,
or g interferons. The increase in IFL8/Kb-specific T cell
cDNA Library, Expression Screens, DNA Constructs,activation could be accounted for by upregulation of H28
and Peptidesgene transcription and was reflected in the enhanced
Construction of unidirectional cDNA libraries and screens for isolat-abundance of the naturally processed peptide in cell
ing T cell–stimulating antigen clones have been described (Karttu-extracts. Thus, neither high MHC binding affinity nor
nen et al., 1992; Shastri, 1996; Malarkannan et al., 1998). Deletionthe natural abundance is adequate explanations for the
constructs were prepared in the pcDNAI vector using internal re-
immunodominance of the H28 and H60 epitopes. striction sites. The minigene constructs encoding Kb1, HSISYRNM;
Could expression by professional APCs explain im- Kb2, MILENFPRL; Kb3, LGHGFLPV; and Kb4, AYKPYKDL and the H60
munodominance? Interestingly, we discovered that both antigenic peptide, MLTFNYRNL, were prepared using complementary
H60 and H28 epitopes were expressed in bone marrow– oligonucleotides corresponding to the indicated sequences. The
derived dendritic cells either constitutively or after inter- peptides, ILENFPRL (IFL8), LTFNYRNL (LYL8), SSWDFITV (SFV8),
feron stimulation. By contrast, the subdominant HY anti- SIINFEKL (SL8), ASNENMETM (NP), and SSVIGVWYL (SIL9) were syn-
thesized, purified by HPLC, and confirmed by mass spectrometry.gen expression was barely detected in the DC and it
Major Minor Histocompatibility Antigens
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In Vitro Translation and Genetic Mapping Bevan, M.J. (1976). Cross-priming for a secondary cytotoxic re-
sponse to minor H antigens with H-2 congenic cells which do notIn vitro translation reactions were carried out with the indicated
cDNA clones and the TnT kit from Promega according to manufac- cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283–1288.
turer’s instructions. Southern and Northern blots analysis was car- Busch, D.H., Pilip, I.M., Vijh, S., and Pamer, E.G. (1998). Coordinate
ried out according to established procedures using the indicated regulation of complex T cell populations responding to bacterial
cDNA fragments as the 32P-labeled probes (Ausubel et al., 1994). infection. Immunity 8, 353–362.
Cerwenka, A., Bakker, A.B.H., McClanahan, T., Wagner, J.E., Wu,
MHC Binding and HPLC Analysis of Naturally Processed Peptides J., Phillips, J.H., and Lanier, L. (2000). Retinoic acid-early inducible
The synthetic IFL8, LYL8, SFV8, and SEL8 peptides were compared genes define a ligand family for the activating NKG2D receptor in
for their relative Kb binding affinity by flow cytometry using RMA/S mice. Immunity 12, 721–727.
cells and the recently described antibody, 25D1.16, that recognizes
Chen, W., Anton, L.C., Bennink, J.R., and Yewdell, J.W. (2000). Dis-the SL8/Kb complex (Porgador et al., 1997; Malarkannan et al., 1998).
secting the multifactorial causes of immunodominance in classNaturally processed peptides were analyzed in cell extracts by re-
I-restricted T cell responses to viruses. Immunity 12, 83–93.verse phase HPLC as described earlier (Malarkannan et al., 1998,
Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N., and Raulet,1999).
D.H. (2000). Novel ligands for the murine NKG2D receptor: expres-
sion by tumor cells and activation of NK cells and macrophages.
Cell Fractionation
Nat. Immunol., in press.
CD31 and B2201 cells were sorted from cells pooled from spleen
Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee,and lymph nodes, CD11c1 cells from bone marrow cells cultured
H.-G. (1991). Allele-specific motifs revealed by sequencing of self-for 7 days in media containing conditioned L-cell supernatant.
peptides eluted from MHC molecules. Nature 351, 290–296.Mac11 cells were from peritoneal exudate cells. Anti-CD3 antibody,
anti-B220, anti-CD11c, and anti-MAC1 antibodies were obtained Greenfield, A., Scott, D., Pennisi, D., Ehrmann, I., Ellis, P., Cooper,
from Pharmingen. Prior to staining with specific antibodies, cells L., Simpson, E., and Koopman, P. (1996). An H-YDb epitope is en-
were incubated with rabbit serum to prevent nonspecific antibody coded by a novel mouse Y chromosome gene. Nat. Genet. 14,
binding. Stained cells were sorted by FACS and incubated overnight 474–478.
with the 100 U/ml of the indicated cytokines (Pharmingen) and used Karttunen, J., Sanderson, S., and Shastri, N. (1992). Detection of
as APC. rare antigen presenting cells by the lacZ T-cell activation assay
suggests an expression cloning strategy for T-cell antigens. Proc.
Enumeration of Antigen-Specific CTL by Intracellular Natl. Acad. Sci. 89, 6020–6024.
IFNg Staining Lindahl, K.F., and Wilson, D.B. (1977). Histocompatibility antigen-
CTL lines or spleen cells from the immunized animals were plated activated cytotoxic T-lymphocytes. II. Estimates of the frequency
out in 96-well U-bottom plates (z1 3 106/well), and incubated for and specificity of precursors. J. Exp. Med. 145, 508–522.
5 hr at 37o with IL-2 (10 U/ml), Golgi Plug (Pharmingen, San Diego,
Little, C.C. (1914). A possible mendelian explanation for a type ofCA, 1 ul/ml) to block cytokine secretion. The cells were cultured in
inheritance apparently non-mendelian in nature. Science 40,medium alone or with 200 nM of synthetic peptides for 5 hr. The
904–906.cells were then stained first with PE-conjugated, anti-CD8 antibody,
Loveland, B., Wang, C.-R., Yonekawa, H., Hermel, E., and Lindahl,fixed, permeabilized, and then stained with FITC-conjugated, anti-
K.F. (1990). Maternally transmitted histocompatibility antigen ofIFNg antibody. All reagents were from the Intracellular IFNg staining
mice: a hydrophobic peptide of a mitochondrially encoded protein.kit from Pharmingen and used according to instructions. Stained
Cell 60, 971–980.cells were analyzed by flow cytometry to enumerate the fraction of
CD81 cells that also contained intracellular interferon-g. Malarkannan, S., Shih, P.P., Eden, P.A., Horng, T., Zuberi, A.R.,
Christianson, G., Roopenian, D., and Shastri, N. (1998). The molecu-
lar and functional characterization of a dominant minor H antigen,Acknowledgments
H60. J. Immunol. 161, 3501–3509.
This research was supported by National Institutes of Health grants Malarkannan, S., Horng, T., Shih, P., Schwab, S., and Shastri, N.
(to N. S. and D. C. R.). S. M. was supported in part by the University (1999). Presentation of out-of-frame peptide/MHC class I complexes
of California Cancer Research Coordination Committee, P. A. E. by by a novel translation initiation mechanism. Immunity 10, 681–690.
a National Institutes of Health training postdoctoral fellowship, T. H.
Matzinger, P. (1991). The JAM test. A simple assay for DNA fragmen-
by the Beckman undergraduate scholarship, and T. H. and P. S.
tation and cell death. J. Immunol. Methods 145, 185–192.
by the Howard Hughes Medical Institute Undergraduate Biology
Mendoza, L., Paz, P., Zuberi, A.R., Christianson, G., Roopenian,Fellows Program. N. B. was supported by the Dutch Cancer Society
D.C., and Shastri, N. (1997). Minors held by majors. The H13 minorand by a postdoctoral fellowship award made possible by the
histocompatibility locus defined as a peptide/MHC class I complex.Wheeler Fund for the Biological Sciences at the University of Califor-
Immunity 7, 461–472.nia, Berkeley.
Murali-Krishna, K., Altman, J.D., Suresh, M., Sourdive, D.J., Zajac,
A.J., Miller, J.D., Slansky, J., and Ahmed, R. (1998). Counting anti-Received June 9, 2000; revised August 8, 2000.
gen-specific CD8 T cells: a reevaluation of bystander activation
during viral infection. Immunity 8, 177–187.
References
Nevala, W.K., and Wettstein, P.J. (1996). The preferential cytolytic T
lymphocyte response to immunodominant minor histocompatibilityAusubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G.,
antigen peptides. Transplantation 62, 283–291.Smith, J.A., and Struhl, K. (1994). Current Protocols in Molecular
Biology (New York: John Wiley & Sons, Inc.). Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R., and Germain,
R.N. (1997). Localization, quantitation, and in situ detection of spe-Bailey, D. (1975). Genetics of histocompatibility in mice. I. New loci
cific peptide-MHC class I complexes using a monoclonal antibody.and congenic lines. Immunogenetics 2, 249–256.
Immunity 6, 715–726.
Bailey, D. (1999). Sizing up the set of H genes in mice. In Minor
Rotzschke, O., Falk, K., Faath, S., and Rammensee, H.-G. (1991).Histocompatibility Antigens: From the Laboratory to the Clinic, D.C.
On the nature of peptides involved in T cell alloreactivity. J. Exp.Roopenian and E. Simpson, eds. (Georgetown, TX: Landes Biosci-
Med. 174, 1059–1071.ence), pp. 15–25.
Sanderson, S., and Shastri, N. (1994). LacZ inducible peptide/MHCBailey, D.W., and Mobraaten, L.E. (1969). Estimates of the number
specific T-hybrids. Int. Immunol. 6, 369–376.of loci contributing to the histocompatibility between C57Bl/6 and
BALB/c strains of mice. Transplantation 7, 394–399. Scott, D.M., Ehrmann, I.E., Ellis, P.S., Bishop, C.E., Agulnik, A.I.,
Immunity
344
Simpson, E., and Mitchell, M.J. (1995). Identification of a mouse
male-specific transplantation antigen, H-Y. Nature 376, 695–698.
Shastri, N. (1996). Needles in haystacks. Identifying specific peptide
antigens for T-cells. Curr. Opin. Immunol. 8, 271–277.
Sijts, A.J.A.M., and Pamer, E.G. (1997). Enhanced intracellular dis-
sociation of major histocompatibility complex class I-associated
peptides: a mechanism for optimizing the spectrum of cell surface-
presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 185, 1403–
1411.
Simpson, E., Scott, D., and Chandler, P. (1997). The male-specific
histocompatibility antigen, H-Y: a history of transplantation, immune
response genes, sex determination and expression cloning. Annu.
Rev. Immunol. 15, 39–61.
Snell, G.D. (1948). Methods for the study of histocompatibility genes.
J. Genet. 49, 87–108.
Wallny, H.-J., and Rammensee, H.-G. (1990). Identification of classi-
cal minor histocompatibility antigen as cell-derived peptide. Nature
343, 275–278.
Wolpert, E., Franksson, L., and Karre, K. (1995). Dominant and cryp-
tic antigens in the MHC class I restricted T cell response across a
complex minor histocompatibility barrier: analysis and mapping by
elution of cellular peptides. Int. Immunol. 7, 919–928.
Zuberi, A., Christianson, G.J., Mendoza, L.M., Shastri, N., and
Roopenian, D.C. (1998). Positional cloning and molecular character-
ization of an immunodominant cytotoxic determinant of the mouse
H3 minor histocompatibility complex. Immunity 9, 687–698.
